Biomarkers Reflecting The Destruction Of The Blood-Brain Barrier Are Valuable In Predicting The Risk Of Lymphomas With Central Nervous System Involvement.
Wenjun YuMengya SiLi LiPing HeZhiqiang FanQiaoxin ZhangXiaoyang JiaoPublished in: OncoTargets and therapy (2019)
CSF biomarkers affecting BBB disruption are valuable in mirroring the risk of lymphoma CNS metastasis. Further study with a larger sample size is needed to verify these biomarkers in predicting lymphoma CNS involvement.